G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP

Science

Volumn 272, Issue 5266, 1996, Pages 1349-1352

  Yamatsuji, Tomoki ^b   Matsui, Takashi ^b   Okamoto, Takashi ^b   Komatsuzaki, Katsumi ^b   Takeda, Shizu ^b   Fukumoto, Hiroaki ^b   Iwatsubo, Takeshi ^b   Suzuki, Nobuhiro ^b   Asami Odaka, Asano ^b   Ireland, Scott ^b   Kinane, T Bernard ^b   Giambarella, Ugo ^b   Nishimoto, Ikuo ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DNA FRAGMENT; GLYCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOLEUCINE; MUTANT PROTEIN; PHENYLALANINE; VALINE;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOMINANT INHERITANCE; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEOSOME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT;

EID: 15844386159     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.272.5266.1349     Document Type: Article

References (44)

1. R. Katzman, N. Engl. J. Med. 314, 964 (1986).
2. J. Kang et al., Nature 325, 733 (1987).
3. R. Sandbrink, C. L. Masters, K. Beyreuther, J. Biol. Chem. 269, 1510 (1994).
4. A. Goate et al., Nature 349, 704 (1991); S. Naruse et al, Lancet 337, 978 (1991); K. Yoshioka, T. Miki, T. Katsuya, T. Ogihara, Y. Sakaki, Biochem. Biophys. Res. Commun. 178, 1141 (1991); J. Murrell, M. Farlow, B. Ghetti, M. D. Benson, Science 254, 97 (1991); M.-C. Chartier-Harlin et al., Nature 353, 844 (1991); J. Hardy, Nature Genet, 1, 233 (1992).
5. A. Goate et al., Nature 349, 704 (1991); S. Naruse et al, Lancet 337, 978 (1991); K. Yoshioka, T. Miki, T. Katsuya, T. Ogihara, Y. Sakaki, Biochem. Biophys. Res. Commun. 178, 1141 (1991); J. Murrell, M. Farlow, B. Ghetti, M. D. Benson, Science 254, 97 (1991); M.-C. Chartier-Harlin et al., Nature 353, 844 (1991); J. Hardy, Nature Genet, 1, 233 (1992).
6. A. Goate et al., Nature 349, 704 (1991); S. Naruse et al, Lancet 337, 978 (1991); K. Yoshioka, T. Miki, T. Katsuya, T. Ogihara, Y. Sakaki, Biochem. Biophys. Res. Commun. 178, 1141 (1991); J. Murrell, M. Farlow, B. Ghetti, M. D. Benson, Science 254, 97 (1991); M.-C. Chartier-Harlin et al., Nature 353, 844 (1991); J. Hardy, Nature Genet, 1, 233 (1992).
7. A. Goate et al., Nature 349, 704 (1991); S. Naruse et al, Lancet 337, 978 (1991); K. Yoshioka, T. Miki, T. Katsuya, T. Ogihara, Y. Sakaki, Biochem. Biophys. Res. Commun. 178, 1141 (1991); J. Murrell, M. Farlow, B. Ghetti, M. D. Benson, Science 254, 97 (1991); M.-C. Chartier-Harlin et al., Nature 353, 844 (1991); J. Hardy, Nature Genet, 1, 233 (1992).
8. A. Goate et al., Nature 349, 704 (1991); S. Naruse et al, Lancet 337, 978 (1991); K. Yoshioka, T. Miki, T. Katsuya, T. Ogihara, Y. Sakaki, Biochem. Biophys. Res. Commun. 178, 1141 (1991); J. Murrell, M. Farlow, B. Ghetti, M. D. Benson, Science 254, 97 (1991); M.-C. Chartier-Harlin et al., Nature 353, 844 (1991); J. Hardy, Nature Genet, 1, 233 (1992).
9. A. Goate et al., Nature 349, 704 (1991); S. Naruse et al, Lancet 337, 978 (1991); K. Yoshioka, T. Miki, T. Katsuya, T. Ogihara, Y. Sakaki, Biochem. Biophys. Res. Commun. 178, 1141 (1991); J. Murrell, M. Farlow, B. Ghetti, M. D. Benson, Science 254, 97 (1991); M.-C. Chartier-Harlin et al., Nature 353, 844 (1991); J. Hardy, Nature Genet, 1, 233 (1992).
10. H. Karlinsky et al., Neurology 42, 1445 (1992).
11. D. Games et al., Nature 373, 523 (1995).
12. U. Müller et al., Cell 79, 755 (1994); H. Zheng et al., ibid. 81, 525 (1995).
13. U. Müller et al., Cell 79, 755 (1994); H. Zheng et al., ibid. 81, 525 (1995).
14. D. Platika, M. H. Boulos, L. Baizer, M. C. Fishman, Proc. Natl. Acad. Sci. U.S.A. 82, 3499 (1985). F11 cells are a mixture of at least four different clones - small and large cells with and without neurite-like processes - although all exhibit neuronal traits. Cells were grown in Ham's F12 medium supplemented with 18% fetal bovine serum (FBS), penicillin, and streptomycin.
15. Y. Gavrieli, Y. Sherman, S. A. Ben-Sasson, J. Cell Biol. 119, 493 (1992). The TUNEL assay was performed with the Apoptag kit (Oncor). This method specifically labels the 3′-OH ends of fragmented nucleosomal DNA in situ in the presence of exogenously added TdT and digoxigenin-labeled dUTP. F11 cells were seeded on a cover glass precoated with poly-D-lysine (Boehringer Mannheim) and cultured for 24 hours in Ham's F12 medium supplemented with 18% FBS and penicillin-streptomycin. After transfection, the cells were cultured for a further 36 hours and then subjected to the TUNEL assay. The extent of DNA fragmentation was quantitated with a Videometric 150 Image Analysis System (Oncor), as described [I. Joffe et al., Calcif. Tissue Int. 53, 45 (1993)]; briefly, it was determined from the ratio of the area of stained cells to the total cell area, the latter of which was obtained after detecting and highlight-ing the edges of all cells in the field. Cell areas were determined as total number of pixels. The maximal extent of DNA fragmentation was ∼10%. For each transfection, data were analyzed to obtain means ± SE of the extent of DNA fragmentation in 20 randomly chosen fields (the SE values were <5% of the mean values in all instances), and the obtained mean values were further analyzed to yield means ± SE for at least three independent transfections. To ensure objective evaluation, different groups of researchers (i) performed transfections as well as stained and numbered the samples; (ii) subjected the anonymous numbered samples to image analysis; and (iii) collected data and collated them with the recorded numbers.
16. Y. Gavrieli, Y. Sherman, S. A. Ben-Sasson, J. Cell Biol. 119, 493 (1992). The TUNEL assay was performed with the Apoptag kit (Oncor). This method specifically labels the 3′-OH ends of fragmented nucleosomal DNA in situ in the presence of exogenously added TdT and digoxigenin-labeled dUTP. F11 cells were seeded on a cover glass precoated with poly-D-lysine (Boehringer Mannheim) and cultured for 24 hours in Ham's F12 medium supplemented with 18% FBS and penicillin-streptomycin. After transfection, the cells were cultured for a further 36 hours and then subjected to the TUNEL assay. The extent of DNA fragmentation was quantitated with a Videometric 150 Image Analysis System (Oncor), as described [I. Joffe et al., Calcif. Tissue Int. 53, 45 (1993)]; briefly, it was determined from the ratio of the area of stained cells to the total cell area, the latter of which was obtained after detecting and highlight-ing the edges of all cells in the field. Cell areas were determined as total number of pixels. The maximal extent of DNA fragmentation was ∼10%. For each transfection, data were analyzed to obtain means ± SE of the extent of DNA fragmentation in 20 randomly chosen fields (the SE values were <5% of the mean values in all instances), and the obtained mean values were further analyzed to yield means ± SE for at least three independent transfections. To ensure objective evaluation, different groups of researchers (i) performed transfections as well as stained and numbered the samples; (ii) subjected the anonymous numbered samples to image analysis; and (iii) collected data and collated them with the recorded numbers.
17. 676 coding sequence and shown not to contain unwanted mutations. The V642IΔH657-K676 cDNA was finally subcloned in pcDNA1 and pECE. The lacZ construct contained the Escherichia coli lacZ gene under the control of the chicken β-actin gene promoter.
18. 6 cells per 100-mm dish (for immunoblot analysis) and cultured for 24 hours in Ham's F12 medium supplemented with 18% FBS and penicillin-streptomycin. Cells were transfected with cDNA with the use of Lipofectamine (Gibco) in serum-free medium. Unless otherwise specified, 0.5 μg of cDNA and 1 μl of Lipofectamine were used for DNA fragmentation assays, and 10 μg of cDNA and 20 μl of Lipofectamine were used for immunoblot analysis. After incubation for 24 hours in serum-free medium, transfected cells were cultured for a further 12 hours in Ham's F12 medium containing 10 nM nerve growth factor (NGF) and antibiotics (in some experiments, cells were cultured in the absence of NGF or in the presence of 10 nM NGF and 1% FBS; the results were similar, although NGF reduced the error bars in the quantitation of DNA fragmentation). Cells were then fixed or lysed. For experiments in which F11 cells were treated with Aβ(1-42), cells were exposed to 50 μM Aβ(1-42) plus 10 nM NGF for 48 hours to simulate the conditions of APP transfection experiments. Because F11 cells contain abundant endogenous APP, we could not identify the individual cells that express transfected APP mutants by immunocytochemistry with antibodies to APP.
19. A. Tamaoka et al., J. Biol. Chem. 269, 32721 (1994); T Iwatsubo et al., Neuron 13, 45 (1994).
20. A. Tamaoka et al., J. Biol. Chem. 269, 32721 (1994); T Iwatsubo et al., Neuron 13, 45 (1994).
21. T Yamatsuji and I. Nishimoto, unpublished data.
22. D. T. Loo et al., Proc. Natl. Acad. Sci. U.S.A. 90, 7951 (1993).
23. 2-terminus as well as full-length Aβ [A. Asami-Odaka et al. Biochemistry 34, 10272 (1995)].
24. X.-D. Cai, T. E. Golde, S. G. Younkin, Science 259, 514 (1993).
25. N. Suzuki et al., ibid. 264, 1336 (1994).
26. I. Nishimoto et al., Nature 362, 75 (1993).
27. J. Lang et al., EMBO J. 14, 3635 (1995).
28. T. Okamoto, S. Takeda, Y. Murayama, E. Ogata, I. Nishimoto, J. Biol. Chem. 270, 4205 (1995).
29. The effect of PTX was clearly preventive, as virtually no DNA fragmentation was observed at 24 hours after transfection with APP mutant cDNAs. Thus, DNA fragmentation appears to occur between 24 and 36 hours after transfection. Given that expression of the APP mutants was already apparent at 24 hours, these data further suggest that the mutants require a 12 hours to achieve DNA fragmentation. In contrast, only 2 to 3 hours were required for PTX to mediate ADP (adenosine diphosphate) ribosylation of G proteins in our system, allowing for the total inhibitory effect of this toxin added 24 hours after transfection.
30. Expression of V642I APP in F11 cells treated with PTX at 100 ng/ml was 100.5 ± 3.9% (mean ± SD of three independent transfections) of that apparent with untreated cells. Secretion of Aβ(1-40) and Aβ(1-42) from V642I APP-expressing F11 cells treated with PTX (100 ng/ml) was 98.3 ± 6.3% and 93.9 ± 8.0% (means ± SE of three independent transfections), respectively, of the corresponding values for untreated cells.
31. M. Igarashi, S. M. Strittmatter, T. Vartanian, M. C. Fishman. Science 259, 77 (1993).
32. i2. Again, the sequence of this plasmid was verified.
33. i2. Again, the sequence of this plasmid was verified.
34. i2. Again, the sequence of this plasmid was verified.
35. i gene promoter responded to an increase in the concentration of adenosine 3′,5′-monophosphate induced by the construct, as described [T. B. Kinane et al., J. Biol. Chem. 268, 24669 (1993)].
36. H. Lassmann et al., Acta Neuropathol. 89, 35 (1995).
37. J. H. Su, A. J. Anderson, B. J. Cummings, C. W. Cotman, Neuroreport 5, 2529 (1994); M, Dragunow et al., ibid. 6, 1053 (1995); G. Smale, N. R. Nichols, D. R. Brady, C. E. Finch, W. E. Horton, Exp. Neurol. 133, 225 (1995).
38. J. H. Su, A. J. Anderson, B. J. Cummings, C. W. Cotman, Neuroreport 5, 2529 (1994); M, Dragunow et al., ibid. 6, 1053 (1995); G. Smale, N. R. Nichols, D. R. Brady, C. E. Finch, W. E. Horton, Exp. Neurol. 133, 225 (1995).
39. J. H. Su, A. J. Anderson, B. J. Cummings, C. W. Cotman, Neuroreport 5, 2529 (1994); M, Dragunow et al., ibid. 6, 1053 (1995); G. Smale, N. R. Nichols, D. R. Brady, C. E. Finch, W. E. Horton, Exp. Neurol. 133, 225 (1995).
40. 695 cDNA, and 0.056 ± 0.001 for cells transfected with 0.5 μg of V642IAPP cDNA (means ± SE of three independent transfections). These data indicate that V642 mutant-induced DNA fragmentation occurs in human neurons.
41. 695 cDNA, and 0.056 ± 0.001 for cells transfected with 0.5 μg of V642IAPP cDNA (means ± SE of three independent transfections). These data indicate that V642 mutant-induced DNA fragmentation occurs in human neurons.
42. V. R. Rao, G. B. Cohen, D. D. Oprian, Nature 367, 639 (1994); G.-Q. Chang, Y. Hao, F. Wong, Neuron 11, 595 (1993].
43. V. R. Rao, G. B. Cohen, D. D. Oprian, Nature 367, 639 (1994); G.-Q. Chang, Y. Hao, F. Wong, Neuron 11, 595 (1993].
44. o(G204A) cDNA; A. H. Tashjian, E. Haber, and J. H. Growdon for helpful discussions; E. Neer and B. Yankner for reading a prior version of this manuscript; M. H. Boulos, Y. Tamai, Y. Murayama, and E. Ogata for support of this work; and D. Wylie and L. Duda for help with preparation of the manuscript.